Selective AXL inhibitors
Date: 10th – 11th March 2021
On the 11th March, BerGenBio CEO Richard Godfrey will be participating in a Virtual Immuno-Oncology Partnering Panel and represent BerGenBio ASA as a Spotlight Presenter at the 14th Annual European Life Sciences CEO Forum.
Further information can be found here: https://www.sachsforum.com/14elsf-about.html
Please remember to confirm your email by clicking on the link provided in the subscription confirmation email. We will save your name and email address with the sole purpose of sending information regarding our latest news and events. By subscribing to BerGenBio’s newsletter you consent to our Privacy Policy and Terms of Use.
